Skip to main content

Table 2 Results to docetaxel plus doxorubicin neoadjuvant chemotherapy

From: Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy

Response No. of Pts (%)
Histopathologic response  
   Pathologic complete response 4 (5.1)
   Minimal residual disease 10 (12.8)
   Gross residual disease 64 (82.1)